Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL). RESULTS: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93. CONCLUSION: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sensitivity and specificity have been estimated to be 69.9 and 87.1%, respectively [47], as there are a high number of false positive results.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“(1 ?3)-b-D-glucan is a component of the cell wall of many fungi and has been proposed as a non-specific marker for invasive fungal infections.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“b-1, 3-D-Glucan detection has also been evaluated in critically ill patients, with sensitivity and specificity for diagnosis of IC estimated to be 69.9% and 87.1%, respectively.63”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [63]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 3×
“Subjects. Subjects without IFI and subjects with proven or probable IFI (determined according to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group [EORTC/MSG] criteria [ 15 ]) from 6 clinical sites in the United States consented to participate in this study, and a single blood samp…”
MethodSelf-citation(2012) · Hepatogastroenterology · doi:10.5754/hge11801 · Cited by 802
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642 · cited 4×
“The reactivity of the Fungitell assay with Pachyman standard is lower than that of the Fungitec-G assay [9].”
BackgroundMethodSelf-citationObayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498 · cited 1×
“parapsilosis [19].”
Self-citationThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323 · cited 1×
“of cases of invasive aspergillosis [4].”
The New Fungal Opportunists Are Coming
Perfect, J. R., & Schell, W. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s112 · Cited by 224 · cited 1×
“critical care [1].”
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Digby, J., Kalbfleisch, J. H., Glenn, A., Larsen, A. R., Browder, W., & Williams, D. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153 · cited 2×
“[18] observed low specificity for fungal infections in a study involving 46 subjects in intensive care units.”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133 · cited 1×
“BG produced by fungi [6] is detected by a glucan assay on the basis of its recognition by the innate immune system of horseshoe crabs, specifically Tachypleus tridentatus and Limulus polyphemus [7].”
Background
Research works printed but not linked: 1
- Nakao, 1997, Hepato-gastroenterology, 44, 1413
Cited by
Items 301–400 of 667
Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy
Lass‐Flörl, C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.128 · Cited by 26
Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review
Elkhapery, A. M. R., Fatima, M., & Soubani, A. O. (2025) · Journal of Fungi · doi:10.3390/jof11080555 · Cited by 27
Dichtl, K., Forster, J., Ormanns, S., Horns, H., Suerbaum, S., Seybold, U., & Wagener, J. (2020) · Journal of Fungi · doi:10.3390/jof6040253 · Cited by 24
Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients
Glöckner, A., & Karthaus, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01885.x · Cited by 25
Improved Detection of Circulating Aspergillus Antigen by Use of a Modified Pretreatment Procedure
Mennink‐Kersten, M. A. S. H., Ruegebrink, D., Klont, R. R., Warris, A., Blijlevens, N. M. A., Donnelly, J. P., & Verweij, P. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02327-07 · Cited by 26
Evaluation of Human Body Fluids for the Diagnosis of Fungal Infections
Badiee, P. (2013) · BioMed Research International · doi:10.1155/2013/698325 · Cited by 23
“Molecular assays can serve as a reliable method for the diagnosis of fungal endocarditis [56].”
MethodMorrissey, C. O., Bardy, P., Slavin, M. A., Ananda-Rajah, M. R., Chen, S. C., Kirsa, S. W., Ritchie, D., & Upton, A. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01724.x · Cited by 22
Penicillium marneffei Infection with β-D-glucan Elevation: A Case Report and Literature Review
Yoshimura, Y., Sakamoto, Y., Kwangyeol, L., Amano, Y., & Tachikawa, N. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6173 · Cited by 22
He, Z.-X., Chen, J., Li, W., Cheng, Y., Zhang, H.-P., Zhang, L., & Hou, T. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00920 · Cited by 28
“These antigenic molecules mainly include (1,3)-D-glucan (BDG) (Ostrosky-Zeichner et al., 2005; Pickering et al., 2005; Cuetara et al., 2009), galactomannan (Sendid et al., 1999), enolase (Walsh et al., 1991), aspartyl proteinase (Morrison et al., 2003), andD-arabinitol (Christensson et al., 1999;…”
BackgroundZaragoza, R., & Pemán, J. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70014-6 · Cited by 25
Sugui, J. A., Rose, S. R., Nardone, G., Swamydas, M., Lee, C.-C. R., Kwon-Chung, K. J., & Lionakis, M. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-10888-9 · Cited by 21
Fungal infections after hematopoietic stem cell transplantation
Asano‐Mori, Y. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0574-0 · Cited by 22
“Clinical usefulness of the (1,3)b-D-glucan assay was also recognized outside of Japan, and Fungitell (Associates of Cape Cod) was approved by the FDA in 2004 [29–32].”
BackgroundSerum 1,3-βD-Glucan Assay in the Diagnosis of Invasive Fungal Disease in Neonates
Mackay, C. A., Ballot, D. E., & Perovic, O. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e14 · Cited by 22
BÖLÜK, G., Kazak, E., Özkalemkaş, F., Ener, B., Akalın, H., Ağca, H., Okuturlar, Y., Keskin, K., BURGAZLIOĞLU, B., & Ali, R. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1408-100 · Cited by 21
Furfaro, E., Giacobbe, D. R., Bono, V. D., Signori, A., Guolo, F., Minetto, P., Clavio, M., Ballerini, F., Gobbi, M., Viscoli, C., et al. (2018) · Mycoses · doi:10.1111/myc.12787 · Cited by 22
Retrospective assessment of β‐ d ‐(1,3)‐glucan for presumptive diagnosis of fungal infections
Bellanger, A., Grenouillet, F., Hénon, T., Skana, F., Legrand, F., Deconinck, É., & Millon, L. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02728.x · Cited by 22
Alonso, M., Escribano, P., Guinea, J., Recio, S., Simón, A., Peláez, T., Bouza, E., & de Viedma, D. G. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00176-12 · Cited by 24
Metan, G., Koç, A. N., Atalay, M. A., Kaynar, L., Öztürk, A., Alp, E., & Eser, B. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.638319 · Cited by 25
“In a multicentre prospective study that included 163 patients with IFIs, the sensitivity and the specifi city were 64% and 92%, respectively, at 80 pg/ml [8].”
BackgroundReischies, F., Prattes, J., Woelfler, A., Eigl, S., & Hoenigl, M. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12527 · Cited by 23
Dupont, H., Mahjoub, Y., Chouaki, T., Lorne, E., & Zogheib, E. H. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002698 · Cited by 22
Wu, J., Xie, S., Zhang, G., Zhan, J., Xie, W., Yu, R., Xue, B., Cen, Y., Chai, J., Chen, H., et al. (2014) · Burns & Trauma · doi:10.4103/2321-3868.130182 · Cited by 24
“In BIFI, G test displays positive from blood sample for 2 times continuously.([36,37]) d.”
Recent advances in the treatment of life-threatening, invasive fungal infections
Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 31
“Based on studies included in a metaanalysis in patients with IFIs, the BDG sensitivity and specificity ranges were 64 to 100% and 33 to 90%, respectively [38-41].”
BackgroundSendid, B., Jouault, T., Standaert‐Vitse, A., Fradin, C., Colombel, J., & Poulain, D. (2009) · médecine/sciences · doi:10.1051/medsci/2009255473 · Cited by 24
Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients
Jantunen, E., Nihtinen, A., & Anttila, V. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2008.00301.x · Cited by 24
“A recent multicenter trial showed a high speci¢city and high positive predictive value (40).”
BackgroundEchinocandin-Resistant Candida: Molecular Methods and Phenotypes
Perlin, D. S. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0054-x · Cited by 22
Pacora, P., Romero, R. J., Erez, O., Maymon, E., Panaitescu, B., Kusanovic, J. P., Tarca, A. L., Hsu, C., & Hassan, S. S. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1416083 · Cited by 23
Liu, Y., Chen, F., Zhu, X., Shen, L., & Zhang, S. X. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00673-15 · Cited by 20
Heyland, D. K., Jiang, X., Day, A. G., & Laverdière, M. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.01.002 · Cited by 20
Mootsikapun, P., Hsueh, P.-R., Talwar, D., Co, V. M., Rajadhyaksha, V., & Ong, M.-L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-219 · Cited by 20
“Blood samples for the Fungitell β-D glucan assay (Associates of Cape Cod, East Falmouth, MA, USA) were analyzed by a single reference laboratory for the study [20].”
MethodFigueras, C., de Heredia, C. D., García‐García, J. J., Navarro, C. M., Ruíz-Contreras, J., Rossich, R., Rumbao, J., Frick, M. A., & Roselló, E. M. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2010.12.012 · Cited by 29
Value of (1-3)-β-D-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia
Mokaddas, E. M., Khan, Z., Ahmad, S., Nampoory, M. R. N., & Burhamah, M. H. A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03608.x · Cited by 27
The Diagnostic and Therapeutic Approach to Fungal Infections in Critical Care Settings
Zaragoza, R., & Pemán, J. (2008) · Cited by 21
Non-Invasive Methods to Diagnose Fungal Infections in Pediatric Patients with Hematologic Disorders
Badiee, P., Hashemizadeh, Z., Ramzi, M., Karimi, M., & Mohammadi, R. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.41573 · Cited by 22
Clinical Features of Chronic Invasive Fungal Rhinosinusitis in 16 Cases
Wang, T., Zhang, L., Hu, C., Li, Y., Wang, C., Wang, X., Zang, H., & Zhou, B. (2019) · Ear Nose & Throat Journal · doi:10.1177/0145561318823391 · Cited by 20
Okuda, T., Okuda, A., Watanabe, N., TAKAO, M., & 高柳, 和. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.1811 · Cited by 23
Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells
Herwald, S. E., & Kumamoto, C. A. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0178-x · Cited by 25
Nucci, M., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00013-x · Cited by 23
Avances y limitaciones del diagnóstico precoz de las infecciones invasoras causadas por levaduras
Pontón, J., & del Palacio, A. (2007) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(07)70041-4 · Cited by 32
(1->3) -D-Glucan Assay in the Diagnosis of Invasive Fungal Infections
Upton, A., Leisenring, W. M., & Marr, K. A. (2006) · Clinical Infectious Diseases · doi:10.1086/501130 · Cited by 20
Alanio, A., Gits‐Muselli, M., Guigue, N., Denis, B., Bergeron, A., Touratier, S., Hamane, S., & Bretagne, S. (2021) · Medical Mycology · doi:10.1093/mmy/myab016 · Cited by 20
Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia
Abe, M., Kimura, M., Araoka, H., Taniguchi, S., & Yoneyama, A. (2014) · Medical Mycology · doi:10.1093/mmy/myu066 · Cited by 19
“Recently, (1,3)-beta-D-glucan (BDG) has been developed as an early and rapid serologic biomarker for detecting invasive fungal infections, and its effectiveness for detecting invasive candidiasis was shown in several articles [6,7].”
BackgroundDiagnosing invasive fungal diseases – limitations of microbiological diagnostic methods
Lass‐Flörl, C., & Mayr, A. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050902878031 · Cited by 22
Pemán, J., & Zaragoza, R. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.128 · Cited by 21
Early serum (1→3)‐β‐D‐glucan levels in patients with burn injury
Shupp, J. W., Petraitienė, R., Jaskille, A. D., Pavlovich, A. R., Matt, S. E., Nguyen, D. T., Kath, M. A., Jeng, J. C., Jordan, M. H., Finkelman, M., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02068.x · Cited by 18
Self-citationMikulska, M., Ullah, N., Magnasco, L., Codda, G., Bartalucci, C., Miletich, F., Sepulcri, C., Willison, E., Vena, A., Giacobbe, D. R., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.02.012 · Cited by 20
Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis
Maertens, J. A. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.019 · Cited by 19
Hartl, B., Zeller, I., Manhart, A., Selitsch, B., Lass‐Flörl, C., & Willinger, B. (2018) · Mycopathologia · doi:10.1007/s11046-017-0238-1 · Cited by 22
Murri, R., Camici, M., Posteraro, B., Giovannenze, F., Taccari, F., Ventura, G., Scoppettuolo, G., Sanguinetti, M., Cauda, R., & Fantoni, M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s181489 · Cited by 20
“In fact, sensitivity of BDG is suboptimal, ranging from 77% to 91%.(24,25) In our study, even at the highest cutoff (≥500 pg/mL), sensitivity was 61%.”
BackgroundCorsi-Vasquez, G., Ostrosky‐Zeichner, L., Pilkington, E. F., & Sax, P. E. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01340-19 · Cited by 18
Self-citationEmerging Microbiology Diagnostics for Transplant Infections: On the Cusp of a Paradigm Shift
Azar, M. M., Gaston, D. C., Kotton, C. N., & Malinis, M. F. (2020) · Transplantation · doi:10.1097/tp.0000000000003123 · Cited by 19
“PCR-based diagnostics for IPA benefit from increased sensitivity when compared with culture (30%–60%) and antigen-based methods including serum galactomannan (sensitivity 71%, specificity 89%),(95) BAL galactomannan (sensitivity 85%, specificity 92%),(96) and serum 1,3-betad-glucan (sensitivity 64%, specificity 92%).(…”
10 Invasive Aspergillosis in the Intensive Care Unit
Meersseman, W. (2013) · Springer eBooks · doi:10.1007/978-3-642-39432-4_10 · Cited by 19
Tomita, M., Miwa, M., Ouchi, S., Oda, T., Aketagawa, J., Goto, Y., & Hayashi, M. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1295 · Cited by 18
Invasive fungal infection--laboratory diagnosis and antifungal treatment.
Shao, P. L., Huang, L., & Hsueh, P. (2006) · PubMed · Cited by 19
Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 34
Kawagishi, N., Satoh, K., Enomoto, Y., Akamatsu, Y., Sekiguchi, S., Fujimori, K., & Satomi, S. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.209.207 · Cited by 17
“D glucan, a panfungal cell wall component, as a potentially promising indicator of invasive fungal infection has been developed (Obayashi et al. 1995, 2004; Ostrosky-Zeichner et al. 2005; Pazos et al. 2005).”
BackgroundRecognition and prevention of nosocomial invasive fungal infections in the intensive care unit
Smith, J. A., & Kauffman, C. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cf25 · Cited by 20
“In one multicenter study, approximately 80% of patients with proven candidiasis had a positive test (54).”
BackgroundProsty, C. J., Luo, O. D., Khalaf, R., Corpo, O. D., McDonald, E. G., & Lee, T. C. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.11.004 · Cited by 20
Fungal Spondylodiscitis: Review
Caldera, G., & Cahueque, M. (2016) · Journal of Spine · doi:10.4172/2165-7939.1000302 · Cited by 19
“A rise in inflammatory such as with cell count, erythrocyte sedimentation rates, and C-reactive protein levels can alert the possibility of a spinal infection [48,49].”
BackgroundMalý, J., Szárszoi, O., Netuka, I., Dorazilová, Z., & Pirk, J. (2013) · Journal of Cardiac Surgery · doi:10.1111/jocs.12258 · Cited by 17
“Both tests havemoderate sensitivity (60% for mannan, 83%when combined with anti-mannan antibodies, 65– 80% for b-D-glucan) and are intended to be used as a screening strategy in patients with candidemia.(42,43) Recently, non-culture-based methods such as DNA detection by PCR have been developed for the rapid diagnosis…”
MethodAnti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies
Magliani, W., Conti, S., Giovati, L., Maffei, D. L., & Polonelli, L. (2008) · Frontiers in bioscience · doi:10.2741/3199 · Cited by 20
Central Nervous System Infections
Zimmer, A. J., Burke, V. E., & Bloch, K. C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0012-2015 · Cited by 16
“BDG is a polysaccharide component of the cell in most fungal organisms and may be detectable in the serum of patients with invasive fungal infections, most commonly due to Aspergillus or Candida spp. with a sensitivity of 70 to 80% and speci fi city of 60 to 80% (124, 125).”
BackgroundBigot, J., Leroy, J., Chouaki, T., Monnier‐Cholley, L., Bigé, N., Tabone, M., Brissot, É., Thorez, S., Maizel, J., Dupont, H., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad274 · Cited by 17
Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico
Pemán, J., & Zaragoza, R. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.002 · Cited by 21
Weinbergerová, B., Kabut, T., Kocmanová, I., Lengerová, M., Pospíšil, Z., Král, Z., & Mayer, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-75132-3 · Cited by 16
Fungal Genomics in Respiratory Medicine: What, How and When?
Brackin, A. P., Hemmings, S., Fisher, M. C., & Rhodes, J. L. (2021) · Mycopathologia · doi:10.1007/s11046-021-00573-x · Cited by 16
Aspectos microbiológicos de la criptococosis en la era post-TARGA
Martín‐Mazuelos, E., & Aller, A. I. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(10)70007-0 · Cited by 21
Contribution of serum biomarkers to the diagnosis of invasive candidiasis
Laín, A., Elguezábal, N., Moragues, M. D., García‐Ruiz, J. C., del Palacio, A., & Pontón, J. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.3.315 · Cited by 16
Invasive fungal infections in cancer patients
Anaissie, E. J., Grazziutti, M., & Nucci, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00020-7 · Cited by 19
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.006 · Cited by 14
Pappas, P. G., Kauffman, C. A., Andes, D. R., Benjamin, D. K., Calandra, T., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B. J., Ostrosky-Zeichner, L. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598961 · Cited by 26
“La detección de b-Dglucano ha demostrado caracterı́sticas de rendimiento buenas en general, con una sensibilidad entre 80% y 90% en pacientes con candidemia [104, 105], confirmando resultados anteriores obtenidos en pacientes con malignidades hematológicas [106].”
BackgroundSelf-citationPfaller, M. A. (2015) · Journal of Fungi · doi:10.3390/jof1020217 · Cited by 19
Rieger, C. T., & Ostermann, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01526.x · Cited by 15
Acute Respiratory Failure in Patients with Hematologic Malignancies
Moreau, A., Peyrony, O., Lemiale, V., Zafrani, L., & Azoulay, É. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.02.001 · Cited by 15
Madhumitha, R., Ramasubramanian, V., Nambi, P., Kumar, D., & Thirunarayan, M. A. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_4_18 · Cited by 16
“D‑glucan (BDG) is a cell wall polysaccharide found in almost all pathogenic fungi with exception of zygomycetes and Cryptococcus.”
InfluentialBloos, F., Held, J., Schlattmann, P., Brillinger, N., Kurzai, O., Cornely, O. A., & Thomas-Rüddel, D. O. (2018) · Trials · doi:10.1186/s13063-018-2868-0 · Cited by 17
The Role of the Laboratory in the Diagnosis of Invasive Candidiasis
Montagna, M. T., Caggiano, G., Borghi, E., & Morace, G. (2009) · Drugs · doi:10.2165/11315630-000000000-00000 · Cited by 17
“It is based on the detection of 1,3-b-Dglucan (BG), a cell-wall component of many fungi.([18]) The test shows an overall sensitivity of 67–100% and an 84–100% specificity, except in cases of cryptococcosis and zygomycosis because the aetiological agents of these fungal infections produce little BG.”
BackgroundCandida pneumonia: What we know and what we don’t
Barkauskas, C. E., & Perfect, J. R. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0004-z · Cited by 16
Usefulness of determination of β-D-glucan in the diagnosis of deep mycosis – experience in Japan
Yoshida, M. W. (2006) · Medical Mycology · doi:10.1080/13693780600897997 · Cited by 16
Seitz, T., Holbik, J., Hind, J., Gibas, G., Karolyi, M., Pawelka, E., Traugott, M. T., Wenisch, C., & Zoufaly, A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00140-22 · Cited by 14
A sensitive sandwich ELISA to measure (1→3)-β-d-glucan levels in blood
Yoneda, A., & Kurokawa, T. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.011 · Cited by 14
Fernández‐Silva, F., Capilla, J., Mayayo, E., Sutton, D. A., Hernández, P., & Guarro, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01484-13 · Cited by 14
Desai, S. S., & Wong, B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-325-7_4 · Cited by 14
Candidainfections in non-neutropenic children after the neonatal period
HACIMUSTAFAOĞLU, M. K., & Çelebi, S. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.104 · Cited by 15
A novel enzyme immunoassay for the measurement of plasma (1 → 3)-β-D-glucan levels
Sunamura, E.-I., Iwasaki, M., Shiina, S., Kitahara, S.-I., Yotani, T., Manabe, M., & Miyazaki, O. (2020) · Journal of Immunological Methods · doi:10.1016/j.jim.2020.112872 · Cited by 13
Yoshida, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179265 · Cited by 15
Aspergillus Infection and Extracorporeal Membrane Oxygenation Support
Garcia, X., Mian, A., Mendiratta, P., Gupta, P., Rycus, P. R., & Prodhan, P. (2012) · Journal of Intensive Care Medicine · doi:10.1177/0885066611432542 · Cited by 13
Fungal infection in solid organ recipients
Fortün, J., Ruíz-Camps, I., Martín‐Dávila, P., & Cuenca‐Estrella, M. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(12)70082-4 · Cited by 14
Predictors of Candida spp. as causative agents of catheter-related bloodstream infections
Nagao, M., Hotta, G., Yamamoto, M., Matsumura, Y., Ito, Y., Takakura, S., & Ichiyama, S. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.08.003 · Cited by 16
del Palacio, A., Alhambra, A., Cuétara, M. S., & Pontón, J. (2007) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(07)70042-6 · Cited by 13
The Cell Wall: Glycoproteins, Remodeling, and Regulation
Munro, C. A., & Richard, M. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch14 · Cited by 14
Persistent catheter-related Rhodotorula mucilaginosa fungemia in a leukemic child
Al‐Obaid, I., Khan, Z., Ahmad, S., Emara, M., Burhama, M., Purohit, P., & Joseph, L. (2011) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2011.02.001 · Cited by 12
“[22] reported that of 12 patients with cryptococcosis, only three had positive results at a cut-off value of 60 pg/ mL, and two had positive results at a cut-off value of 80 pg/ mL.”
BackgroundTerada, M., Ohki, E., Yamagishi, Y., Nishiyama, Y., Satoh, K., Uchida, K., Yamaguchi, H., & Mikamo, H. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.108 · Cited by 12
Opportunistic and fungal infections of the lung
José, R. J. P., & Brown, J. (2012) · Medicine · doi:10.1016/j.mpmed.2012.03.013 · Cited by 14
How to treat severe infections in critically ill neutropenic patients?
Zafrani, L., & Azoulay, É. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-512 · Cited by 18
“Nodular or cavitary lesions are suggestive of invasive filamentous fungal infection; however, differential diagnoses include pneumonia due to other microorganisms including mycobacteria, Nocardia, Pneumocystis or Pseudomonas aeruginosa as well as lung involvement by underlying malignancies, so that comparison to previ…”
BackgroundCandida : What Should Clinicians and Scientists Be Talking About?
Spellberg, B. J., Marr, K. A., & Filler, S. G. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch1 · Cited by 15
Defining a case of invasive aspergillosis by serum galactomannan
Maertens, J. A., Theunissen, K., Deeren, D., Meersseman, W., & Eldere, J. V. (2006) · Medical Mycology · doi:10.1080/13693780600835732 · Cited by 15
Fungal Infection in Burn Patents
Tu, Y., Lineaweaver, W. C., Breland, A., & Zhang, F. (2021) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000002865 · Cited by 11
The Tell-Tale Heart:Aspergillus fumigatusEndocarditis in an Immunocompetent Patient
Vohra, S., Taylor, R., & Aronowitz, P. B. (2013) · Hospital Practice · doi:10.3810/hp.2013.02.1017 · Cited by 11
Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B
de Lacerda, J. F., & Meneses-Oliveira, C. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-012-0023-3 · Cited by 11
“The combined detection of antigen and antibody in patients with clinically confirmed candidiasis showed a sensitivity and specificity of 80 % and 93 %, respectively [65, 74, 75].”
BackgroundSeyedmousavi, S., Melchers, W. J. G., Verweij, P. E., & Mouton, J. W. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.08.001 · Cited by 14
Metadata
- Authors
- Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A., & Rex, J. H.
- Affiliations
- Duke University (US)
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Seikagaku Corporation (Japan) (JP)
- University of Florida Health (US)
- College of Idaho (US)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 654-659
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127508258
- Cited by
- 669
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 25 · 2018: 25 · 2017: 21 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 42 · 2012: 39
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- β-1,3-glucan, invasive fungal infections, fungal infection diagnosis, candidiasis, aspergillosis, Fusarium, Mucor, Rhizopus, Cryptococcus, antifungal therapy, sensitivity and specificity, cut-off values, interlaboratory agreement, serum biomarkers, EORTC/MSG criteria
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mycoses, Proteoglycans, Sensitivity and Specificity, Reproducibility of Results, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.